Cibus, Inc.
Cibus, Inc. (NASDAQ: CIBUS) is an agricultural biotechnology company headquartered in San Diego, California. The company's website is www.cibus.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Cibus, Inc. does
In the company’s own words
Cibus, Inc. (NASDAQ: CIBUS) is an agricultural biotechnology company headquartered in San Diego, California. The company's website is www.cibus.com.
Cibus develops plant traits using proprietary gene editing technologies to address productivity, profitability, sustainability, and yield challenges in farming. The company's core platform is the Rapid Trait Development System (RTDS), a time-bound and predictable gene editing process that enables trait development in as little as one year by directly editing seed companies' elite germplasm. This approach distinguishes Cibus from traditional GMO technologies, which integrate foreign DNA and face greater regulatory and adoption barriers globally.
The company operates within the global seed market, where trait value across both GMO and non-GMO seeds represents approximately twelve billion dollars. Cibus' primary business focuses on licensing plant traits to seed companies for royalty payments. The company's priority program centers on rice herbicide tolerance traits, which represent estimated potential annual addressable royalties exceeding two hundred million dollars upon full commercialization in the United States and Latin America, with expansion planned to Asia and India by 2030. The company has established seven rice partners representing approximately five to seven million peak addressable acres.
Beyond its core trait licensing model, Cibus pursues alternative partnership arrangements and explores sustainable ingredients opportunities, including biofragrance products developed through yeast genetics and fermentation. The company completed pre-commercial pilot runs for biofragrance products in 2025 and maintains a collaboration with Procter & Gamble on sustainable low-carbon ingredients.
Cibus retains rights to a broader productivity trait portfolio including canola, soybean, wheat, and alfalfa programs, which the company pursues through opportunistic, partner-funded projects. The company has achieved significant regulatory progress, including FDA pre-market meeting completions for multiple traits and positive determinations from the USDA-APHIS, with seventeen total positive regulatory determinations on Cibus technologies. Recent EU regulatory developments establishing frameworks for gene-edited plants represent substantial future market opportunities for the company's trait pipeline.
Company details
- Sector
- Materials
- Industry
- Chemicals
- Headquarters
- SAN DIEGO, CA
- Fiscal year end
- December
- CIK
- 1705843
- SIC
- 2870
Financial performance, year by year
Fiscal 2017–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Cibus, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Cibus, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Cibus, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Cibus, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Cibus, Inc.'s last four quarterly filings that the numbers alone won't show?”